TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Glycorex Transplantation AB (publ)
Closing information (x1000 EUR)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 3,245 | 2,758 | 2,690 |
Financial expenses | 22 | 39 | 34 |
Earnings before taxes | -766 | -1,197 | -802 |
EBITDA | 22 | -327 | 11 |
Total assets | 8,634 | 9,954 | 11,227 |
Current assets | 4,083 | 4,944 | 5,773 |
Current liabilities | 1,422 | 1,322 | 1,134 |
Equity capital | 6,682 | 8,111 | 9,485 |
- share capital | 332 | 361 | 348 |
Employees (average) | 22 | 24 | 22 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 77.4% | 81.5% | 84.5% |
Turnover per employee | 148 | 115 | 122 |
Profit as a percentage of turnover | -23.6% | -43.4% | -29.8% |
Return on assets (ROA) | -8.6% | -11.6% | -6.8% |
Current ratio | 287.1% | 374.0% | 509.1% |
Return on equity (ROE) | -11.5% | -14.8% | -8.5% |
Change turnover | 711 | 118 | -907 |
Change turnover % | 28% | 4% | -25% |
Chg. No. of employees | -2 | 2 | 1 |
Chg. No. of employees % | -8% | 9% | 5% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.